{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-048815","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.682237+00:00","generated_at":"2026-05-17T00:42:02.117790+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"agilon health Q3 net loss $110M; re-establishes FY2025 guidance with negative EBITDA outlook","bullets":["Q3 2025 revenue $1.44B, down 1% YoY; net loss $110M vs $118M loss in Q3 2024.","Adjusted EBITDA loss $91M; medical margin negative $57M; gross profit negative $68M.","Total members 618,000 (503k MA, 115k ACO), down 6% YoY due to market exits.","Full-year 2025 guidance: revenue $5.81B-$5.83B; adjusted EBITDA loss ($270M)-($245M).","Expects $30M operating cost reductions in 2026; risk adjustment revenue shortfall of $73M in Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-048815","json":"https://secwatch.observer/filing/0001628280-25-048815.json","markdown":"https://secwatch.observer/filing/0001628280-25-048815.md","text":"https://secwatch.observer/filing/0001628280-25-048815.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828025048815/0001628280-25-048815-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828025048815/agl-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:42:02.117790+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}